
CL
USDColgate-Palmolive Company Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$75.800
고가
$76.585
저가
$75.000
거래량
6.40M
기업 기본 정보
시가총액
61.7B
산업
Household & Personal Products
국가
United States
거래 통계
평균 거래량
5.80M
거래소
NYQ
통화
USD
52주 범위
AI 분석 리포트
마지막 업데이트: 2025년 11월 2일Colgate-Palmolive (CL): Mixed Signals Near Key Support Level
Company Overview
Colgate-Palmolive (CL), a leader in household and personal care products, operates with 34,000 employees across categories like oral hygiene, pet nutrition, and home care. Its current stock price ($76.51) sits near a 52-week low ($74.62), with a market cap of $62.3B and a P/E ratio of 19.96. The company recently cut its annual sales forecast, citing weak consumer demand, after reporting Q3 revenue growth of 1.9%--below analyst expectations.
Price Action Review
Over the past three months:
- Trend: Bearish. Shares dropped 10.8% from $85.78 (Aug 20) to $76.51 (Oct 31).
- Volatility: Low (avg volume: 5.7M shares), though sudden sell-offs occurred in late October (e.g., $79.86 → $77.14 in 3 days).
- Key Levels:
- Support: $76.37 (Bollinger Band lower bound).
- Resistance: $85.43 (Oct 20 high) and $88.84 (analyst price target).
Technical indicators suggest a bullish breakout is possible if prices hold above $74.95 (stop-loss level). The MACD golden cross and surging On-Balance Volume (15.4x average) hint at short-term buying pressure.
News Sentiment Analysis
Recent headlines show conflicting signals:
- Negative: CL lowered its annual sales forecast on Oct 31, citing "rising economic uncertainty" impacting demand for premium-priced products--even in essentials like toothpaste.
- Neutral: Q3 organic sales rose just 0.4%, dragged down by a "non-strategic exit from private-label pet sales."
- Positive: JP Morgan reiterated an "Overweight" rating on Oct 10, though cutting its price target from $95 to $88.
Analyst sentiment remains optimistic
관련 뉴스
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive with a Equal-Weight and lowers the price target from $82 to $80.
Procter & Gamble can be sued over Kid's Crest packaging, US judge rules
Procter & Gamble must face a lawsuit alleging that its packaging for Kid's Crest suggests that children can use more of the toothpaste than is safe.
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90
UBS analyst Peter Grom maintains Colgate-Palmolive with a Buy and lowers the price target from $92 to $90.
Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95
Citigroup analyst Filippo Falorni maintains Colgate-Palmolive with a Buy and lowers the price target from $105 to $95.
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive with a Overweight and lowers the price target from $96 to $87.
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive with a Overweight and lowers the price target from $88 to $87.
Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $94
Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive with a Outperform and lowers the price target from $100 to $94.
AI 예측Beta
AI 추천
업데이트 시간: 2025년 11월 5일 오전 07:26
64.8% 신뢰도
리스크 & 트레이딩
진입점
$76.25
익절
$78.60
손절
$74.86
핵심 요소
관련 주식
DAR
Darling Ingredients Inc.
PGZ
Principal Real Estate Income Fund Common Shares of Beneficial Interest
BGX
Blackstone Long Short Credit Income Fund Common Shares
SGHC
Super Group (SGHC) Limited Ordinary Shares
GHG
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기